Effectiveness and persistence of golimumab as a second biological drug in patients with spondyloarthritis: A retrospective study
Alegre-Sancho, Juan J., Juanola, Xavier, Rodríguez-Heredia, José M., Manero, Javier, Villa-Blanco, Ignacio, Laiz, Ana, Arteaga, María J., Cea-Calvo, Luis, González, Carlos M.
Published in Medicine (Baltimore) (02.04.2021)
Published in Medicine (Baltimore) (02.04.2021)
Get full text
Journal Article
Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada
Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason
Published in Rheumatology international (01.07.2017)
Published in Rheumatology international (01.07.2017)
Get full text
Journal Article
220 Cost per response for abatacept versus adalimumab in patients with seropositive erosive, early rheumatoid arthritis in the United States, Germany, Spain and Canada
Foo, Jason, Rodríguez-Heredia, José M R, Polanco Sánchez, Carlos, Mtibaa, Mondher, Herrmann, Kirsten H, Alemao, Evo, Postema, Roelien, Baerwald, Christoph
Published in Rheumatology (Oxford, England) (01.04.2018)
Published in Rheumatology (Oxford, England) (01.04.2018)
Get full text
Journal Article